1)Alaggio R, Amador C, Anagnostopoulos L, et al. The 5 th edition of the World Health Organization Classification of Haematolymphoid Tumours:Lymphoid Neoplasms. Leukemia 36:1720-1748, 2022
2)Campo E, Jaffe ES, Cook JR, et al. The International Consensus Classification of Mature Lymphoid Neoplasms:a report from the Clinical Advisory Committee. Blood 140:1229-1253, 2022
3)National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas:summary and description of a Working Formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project. Cancer 49:2112-2135, 1982
4)Stansfeld AG, Diebold J, Noel H, et al. Updated Kiel classification for lymphomas. Lancet 1:292-293, 1988
5)Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms:a proposal from the International Lymphoma Study Group. Blood 84:1361-1392, 1994
6)Jaffe ES, Harris NL, Stein H, et al. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. WHO Classification of Tumours, 3rd ed. IARC press, Lyon, 2001
7)MathéG, Rappaport H, O'Conor GT, et al. Histological and cytological typing of neoplastic diseases of haematopoietic and lymphoid tissues. International Histological Classification of Tumours, No. 14. WHO, Geneva, 1976
8)須知泰山,若狭治毅,三方淳男,他.非ホジキンリンパ腫病理組織診断の問題点—新分類の提案.最新医 34:2049-2062, 1979
9)Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127:2375-2390, 2016
10)Swerdlow SH, Campo E, Harris NL, et al(eds). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, revised 4th ed. UARC, Lyon, 2017
11)Cree IA. The WHO classification of Haematolymphoid Tumours. Leukemia 36:1701-1702, 2022
12)Swerdlow SH, Campo E, Arber DA, et al. Response to “The WHO classification of haematolymphoid tumours”(Editorial). Leukemia 36:2748-2749, 2022
13)Takeuchi K, Yokoyama M, Ishizawa S, et al. Lymphomatoid gastropathy:a distinct clinicopathologic entity of self-limited pseudomalignant NK-cell proliferation. Blood 116:5631-5637, 2010